News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Philly Tech Week’s Pennovation Zone
Pennovation Works hosted "The Pennovation Zone,"an interactive area that featured Pennovation Works members, tenants and Accelerator alumni shared insights on their current projects.
5 Penn Teams Accepted into NSF I-Corps Mid Atlantic Hub’s Biotech Cohort
These teams will get hands-on customer discovery, value-prop testing and mentor guidance to bring their innovation to market.
Smart Dosimetry System (SDS) Accepted into National NSF I-Corps Program
The program awards $50,000 to advance groundbreaking technologies through intensive customer discovery and market validation.
Penn’s Chief Innovation Officer John Swartley Interviewed by BioBuzz
In the interview, Dr. Swartley talks about how he leads and supports innovation initiatives across Penn and his career in technology transfer.
PCIV 2024 Showcase at Pennovation Works
Thirty companies, including PCIV portfolio startups and Pennovation Accelerator alumni, presented their work to more than 175 attendees.
Pennovation Accelerator’s 2024 Pitch Day
12 startups presented their business ideas after completing a six-week program focused on business development.
The Bayh-Dole Coalition Releases Third-Annual “Faces of American Innovation” Report
This year's report highlights the stories of trailblazers whose visionary work in bringing early scientific breakthroughs to the marketplace has made a lasting impact on society.
Press Highlights of FY25
During the 2025 fiscal year, there were 119 press mentions for PCI-supported programs, startups and partners. Some of the most popular and widely circulated stories are included here.
Penn Researchers Develop Novel Platform to More Efficiently Produce mRNA Delivery Particles
This new method not only allows for rapid production but also enables precise targeting the LNPs to specific organs like the liver, lungs and spleen.
Penn Medicine researchers use AI to uncover potential antibiotic compounds
The researchers used AI to analyze the genomes of tens of thousands of bacteria and other primitive organisms.